Rio to consider potential Guinea offering

Was it criminal activity that allowed Rio to lose half its project or was it legal? Sam Walsh says he's still interested.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rio Tinto (ASX: RIO) has a poor history of acquisitions and management of projects but – this time – it wasn't their fault.

In the West African country of Guinea, Rio has held onto licences for its huge Simandou iron ore deposit for 13 years, but in 2006 it was was stripped of half its mine. Blocks numbered 1 and 2 were taken and given to BSG Resources (owned by Israel billionaire Beny Steinmetz), which has left many questions to be answered.

The Guinean and U.S. governments have begun criminal investigations into the sale of the blocks but both BSG and Steinmetz have argued it was legal and say they would defend their actions in court. BSG President Asher Avidan said, "Rio is not interested in developing these assets, they want to prevent others from doing so in order to maintain a competitive advantage."

Rio CEO Sam Walsh said that if the lots became available he would be interested. Rio is in talks with the Guinean government to move the project from its settlement agreement and into an investment framework. Rio paid $700 million to the government in 2011 when it signed the agreement and gave it a 35% stake in Rio's Simandou mine and a 51% stake in the port and rail infrastructure. It has been estimated the project could possibly cost up to $20 billion to develop.

Foolish takeaway

Iron ore companies such as Rio, BHP (ASX: BHP) and Fortescue (ASX: FMG) have risen in share price in recent weeks, buoyed by a resilient iron ore price. However it is unlikely to last, with many commodities analyst's predicting downwards pressure to be put on the spot price thanks to oversupply and weak demand from China. This Fool is steering clear of iron ore stocks and is instead looking for companies with huge growth potential and high yields.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »